Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3240 |  IRD Opus Genetics, Inc. - Common Stock | 4.01 USD | -0.99% | +0.75% | -1.23% | +7.80% | 326.40 M USD | ||
| 3241 |  IMRX Immuneering Corporation - Class A Common Stock | 5.27 USD | +3.33% | +4.98% | +32.75% | +29.80% | 340.96 M USD | ||
| 3263 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.85 USD | -5.63% | -6.56% | +47.67% | +156.76% | 332.19 M USD | ||
| 3266 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.32 USD | 0.00% | +1.54% | +9.09% | -23.26% | 329.07 M USD | ||
| 3269 |  OABI OmniAb, Inc. - Common Stock | 2.28 USD | -1.72% | -4.60% | -1.30% | +9.09% | 330.54 M USD | ||
| 3297 |  HELP Cybin Inc. - Common Stock | 5.90 USD | -2.16% | -9.79% | +45.68% | -34.23% | 304.63 M USD | ||
| 3307 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.35 USD | -0.42% | +18.09% | +48.73% | +422.22% | 316.22 M USD | ||
| 3319 |  FBRX Forte Biosciences, Inc. - Common Stock | 20.36 USD | -8.49% | -2.54% | +28.94% | -30.63% | 282.71 M USD | ||
| 3348 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.90 USD | -1.49% | -4.53% | +41.23% | +8.08% | 290.88 M USD | ||
| 3355 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.90 USD | -0.76% | -2.74% | +7.73% | +12.72% | 301.03 M USD | ||
| 3359 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.62 USD | -6.36% | +0.62% | -1.82% | +80.00% | 300.16 M USD | ||
| 3374 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.49 USD | -2.60% | +2.28% | +85.54% | +108.84% | 295.70 M USD | ||
| 3384 |  MGNX MacroGenics, Inc. - Common Stock | 4.59 USD | -3.37% | +0.22% | +17.09% | +208.05% | 291.75 M USD | ||
| 3396 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.77 USD | -3.33% | -2.84% | +10.88% | +53.25% | 288.27 M USD | ||
| 3397 |  TTRX Turn Therapeutics Inc. - Common Stock | 11.37 USD | +17.10% | +61.97% | +122.94% | +13.70% | 338.69 M USD | ||
| 3401 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.25 USD | -2.68% | -2.42% | +13.46% | +4.02% | 281.45 M USD | ||
| 3403 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.42 USD | -9.36% | -17.12% | -9.02% | +27.37% | 274.05 M USD | ||
| 3421 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.36 USD | -2.61% | +2.75% | -0.30% | -32.53% | 267.60 M USD | ||
| 3450 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.04 USD | -2.85% | -22.38% | -19.07% | +78.79% | 264.79 M USD | ||
| 3453 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.99 USD | -2.93% | +0.51% | +20.61% | -2.45% | 262.74 M USD |
Nouvelles Biotechnology Stocks
Un analyste voit un potentiel de vente de plusieurs milliards de dollars pour la thérapie phare de Zura Bio | Benzinga France
L'Immunome franchit une étape réglementaire clé alors que son médicament phare fait l'objet d'un examen par la FDA | Benzinga France
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
 VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |